Tapestry Beats Fiscal Q1 2027 Estimates as Revenue Rises 11% to $1.89B

Tapestry (TPR) beat estimates for the fiscal first quarter of 2027 on both revenue and adjusted EPS. Revenue was $1.89 billion, up 11% from a year earlier, above the $1.85 billion estimate, and adjusted EPS was $1.82, up 32% from a year earlier, above the $1.56 estimate.

Shares rose 4.3% in premarket trading as of 6:45 a.m. ET, to $130.76 from a $125.33 close.

Fiscal Q1 2027 scorecard

By our calculation, revenue was $47.0 million above the estimate and adjusted EPS was $0.26 above it. The QoQ column compares with the previous quarter's revenue of $1.88 billion and adjusted EPS of $1.32. The YoY column compares with $1.70 billion and $1.38 in the same quarter a year earlier.

Track record

• EPS record. Adjusted EPS beat the estimate in 8 of the last 8 reports, including this one.
• Revenue record. Revenue beat the estimate in 7 of the last 8 reports.
• Revenue trend. Revenue over the last 5 reports, oldest first: $1.70 billion, $2.50 billion, $1.92 billion, $1.88 billion and $1.89 billion.

What to watch

• Next-quarter estimates. Consensus calls for EPS of $3.02 and revenue of $2.65 billion next quarter, based on 11 analysts.
• Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 11% increase to $1.89 billion.
• Estimate record. Whether Tapestry extends a record of beating EPS estimates in 8 of its last 8 reports.
• Related coverage. See our reports on Cardinal Health, Zai Lab, BeOne Medicines and NewAmsterdam Pharma.

Sources: Results are from Tapestry's Nov. 5, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Tapestry's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.